Discover Elsevier’s open access options in Biochemistry, Genetics and Molecular Biology

We understand that swift access to quality research is vital in Biochemistry, Genetics and Molecular Biology. We also recognize that your findings have the potential to change lives, so naturally you want them to reach the widest audience possible.

Did you know that there are a range of ways you can make your work open access (OA) with Elsevier? Over the past five years, we’ve watched authors embrace the OA route in this field, leading to a 670% rise in articles published in our open access journals alone!

Why publish OA with Elsevier?

There are plenty of good reasons. We offer you:

  • Choice: We have full open access Biochemistry journals and subscription journals that support open access publishing. All journals also provide a green open access option. In addition, we offer you choice when it comes to the user licenses that define how readers can reuse your OA content.
  • Quality: All published articles are peer reviewed. Our journals have established reputations, high readership and many have strong CiteScores and Impact Factors.
  • Integrity: All journals are indexed by Scopus and DOAJ (Directory of Open Access Journals).
  • Experience: As active researchers in their fields, our journal editors bring a wealth of knowledge.
  • Options to store, share, discover and reuse research data
  • Support complying with policies. We have established a number of agreements with organizations such as the Wellcome Trust and Research Councils UK.
  • Reach: Articles are immediately and permanently free to read and download from our publishing platform ScienceDirect. Because articles are tagged open access, the 17 million users per month can easily search, browse and set up alerts. We also support industry initiatives such as ORCID, Crossref and CHORUS

What motivates authors to choose the OA route…

Dr. Mary Anne D. Chiong, MD, MSc, FPPS

Mary Anne Chiong Director Institute of Human Genetics, NIH-UP Manila, Philippines

Published open access in Molecular Genetics and Metabolism Reports
“Given its reputation on professional, authentic, reliable and very scientific review process, it was really an honor for our manuscript to be part of this esteemed journal.”

Dr. Marius Henkel

Marius Henkel University of Hohenheim, Stuttgart, Germany

Published open access in Biotechnology Reports


“We received more than a quarter of a million euros in total in funding based on the two publications in Biotechnology Reports to continue our work”

Dr. Shin Jae Lee

Shin Lee ETH Zürich, Zürich, Switzerland

Published open access in Molecular Metabolism


“Molecular Metabolism is a relatively new journal but it has a good impact factor and publishes high quality studies. I particularly like the journal policy about the fast review and editorial decision process.”

Dr. Edward Moreira Bahnson

Edward Moreira Bahnson University of North Carolina, Chapel Hill, USA

Published open access in Redox Biology


“As a junior faculty, having this paper published puts me in a much better position to apply for funding.”

Dr. Ugochukwu Offor

Ugochukwu Offor Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa

Published open access in Toxicology Reports

“The responses we are getting to our article are very positive – this could place us in a top position with our scientific findings, paving way for us to make new connections and reach new heights.”

Dr. Chang Xu

Chang Xu Senior Biostatistician at QIAGEN, USA

Published open access in Computational and Structural Biotechnology Journal

“Overall, the review process was relatively fast, and very helpful in improving the paper.”

Professor Atanas G. Atanasov, PhD

Professor Atanas G. Atanasov, PhD Head of the Molecular Biology Department at the Institute of Genetics and Animal Breeding, Poland

Published in Biotechnology Advances
“Not everyone has subscription access, so if you publish OA, more people see your work and then hopefully cite it. Citations are often used as a research importance indicator and can decide whether you get a new grant, or even a new job.”

Professor Balaraman Kalyanaraman, PhD

Professor Balaraman Kalyanaraman Chair of Biophysics at the Medical College of Wisconsin, USA

Published open access in Redox Biology

“For me, it was wonderful that students anywhere in the world could access it.  The only way to make things really stick with students is to make it easily available. Then, I noticed that lecturers at institutions were downloading the slides, so the paper has reached a new group of students through them.”

...And what our editors think about OA

Dr. Gupta Udatha, PhD

Dr. Gupta Udatha Project Manager for the Oslo Cancer Cluster, Norway

Co-founder of open access journal Computational and Structural Biotechnology Journal
“Many open access journals are still relatively new which means they aren’t yet very well known in their communities and are still building their reputation.”

Professor William Alex Clarke, PhD

Professor William Alex Clarke.jpgDirector of Clinical Toxicology and Professor of Pathology at The Johns Hopkins Hospital, USA

Co-Editor-in-Chief of open access Practical Laboratory Medicine
“I work at Johns Hopkins University School of Medicine and one of the key pillars in our institutional mission is the dissemination of knowledge...”

Professor Peter Kohl, MD

Professor Peter Kohl, MD.jpgScientific Director of Universitäts-Herzzentrum, and Director, Institut für Experimentelle Kardiovaskuläre Medizin, Germany

Co-Editor of Progress in Biophysics & Molecular Biology which supports open access.
“We probably have unnecessary double work taking place in the Biosciences. I’m sure open access helps prevent that figure rising.”

Dr. Sergio Pantano, PhD

Dr. Sergio Pantano, PhDBiomolecular Simulations Group Lead at Pasteur Institut in Montevideo, Uruguay

Editor-in-Chief open access journal MethodsX and Editor for Biochemical and Biophysical Research Communications
“One of the big advantages of OA is that people see the full content on the publisher’s platform.”

Professor Tilman Grune, PhD

Professor Tilman Grune, PhDScientific Director of the German Institute of Human Nutrition (DIfE) and Chair of the Department of Molecular Toxicology, DIfE/University of Potsdam, Germany

Co-Editor-in-Chief of open access journalRedox Biology
“Is OA a consideration for me when I publish? Always, always… It’s about visibility, acceptance of ideas by the wider public and citations.”

Professor Tom Blundell, FRS, FMedSci

Professor Tom Blundell FRS, FMedSci.jpgEmeritus Professor and Director of Research in the Department of Biochemistry at the University of Cambridge, UK

Co-Editor of Current Opinion in Structural Biology and Progress in Biophysics & Molecular Biology
“We need an open policy that recognizes inequality of resources in some countries and ensures we don’t unfairly discriminate...”

Ready to publish OA with Elsevier?

You can select one of our open access Biochemistry, Genetics and Molecular Biology titles:

View Articles published in Biochemistry and Biophysics ReportsBiochemistry and Biophysics Reports

Find out more
Submit  paper
Biotechnology ReportsBiotechnology Reports

Find out more
Submit paper

Computational and Structural Biotechnology Journal
Find out more
Submit paper

EuPA Open Proteomics

Find out more
Submit paper

Metabolic Engineering Communications

Find out more
Submit paper

Molecular Genetics and Metabolism Reports

Find out more
Submit paper

Matrix Biology Plus

Find out more
Submit paper

Practical Laboratory Medicine

Find out more
Submit paper

Stem Cell Research

Find out more
Submit paper

Or submit to one of our multidisciplinary open access titles – they all welcome Biochemistry submissions:

We also have subscription journals in Biochemistry, Genetics and Molecular Biology ready to receive your gold OA submission:

View full list of Biochemistry, Genetics and Molecular Biology journals here

Our APC (article publishing charge) fees range between $500 and $4,150 US Dollars excluding tax, and are comparable with other publishers. Specific prices can be found on the individual journal homepages.

  • Open access at Elsevier
  • The Creative Commons user licenses on offer.
  • The agreements we have in place with institutions and funding bodies to help you comply with OA policies.
  • Our approach to open access pricing. Learn how we determine APCs and why we never double dip (i.e. charge our subscribers for open access articles).
  • Share Links. These personalized URLs offer 50 days’ free access to your newly published article on ScienceDirect.
  • Journal finder. Smart technology that helps you identify the right home for your research. Searches can be limited to titles offering OA options.
  • Navigate your research journey with Researcher Academy. Free e-learning modules developed by global experts. Career guidance and advice including on Funding and Ensuring Visibility.

Did you know?

Elsevier is a founding partner of Research4Life, which provides free or low cost research to institutions in the developing world. As well as technical and communications expertise, we have contributed more than a quarter of its nearly 79,000 peer-reviewed resources - approximately 2,500 Elsevier journals and 20,000 ebooks, as well as Scopus, Mendeley and Clinical Key, a point of care database for doctors.